glp 1 agonist perioperative How should we approach patients on GLP-1 agonists? Check out this excellent editorial from Dr. Girish Joshi, "Clarifying the Guidelines and Decoding the Enigma: Strategies for Anesthetic Management of Patients on Glucagon-Like Elective peri‐operative management of adults

Manufacturer Ambiguity: Listings often hide the actual manufacturer, making lot traceability impossible

10.1074/jbc.M707965200 95 SinghD

Studies in neurodegenerative disease models suggest Dihexa's regenerative capabilities extend to reversing existing damage rather than merely preventing further deterioration

Left untreated, Lyme-induced inflammation damages cells, tissues, and organs, inducing widespread bodily dysfunction

The STEP 5 trial demonstrated that continued treatment for 104 weeks maintained weight loss, while the STEP 1 extension study showed that discontinuing semaglutide at 68 weeks led to two-thirds of the weight lost being regained within a year